WebBEIJING, CHINA, April 29, 2024 – Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate Biocytogen’s proprietary antibodies against at least three distinct targets with an option to acquire some of the assets at a later date … WebOct 17, 2024 · BEIJING-- ( BUSINESS WIRE )--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) will present at the upcoming BIO-EUROPE conference in Leipzig, Germany on October 24-26...
Biocytogen Expands Global Footprint with the Opening of Biocytogen …
WebBiocytogen is dedicated to the development of novel antibody drugs to meet the unmet medical needs, with a particular focus on oncology, autoimmune, inflammatory, metabolic, and other diseases. The company’s pipeline includes more than 10 assets including monoclonal antibodies, bispecific antibodies, bispecific ADCs, etc. WebApr 11, 2024 · Company Profile 02315. Business Description. Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. port of kahului harbor
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) - Yahoo …
WebMar 20, 2024 · Biocytogen Pharmaceuticals Beijing Co Ltd is a China-based company mainly engaged in drug development business and preclinical research. The Company … WebApr 6, 2024 · Biocytogen Pharmaceuticals Beijing Co Ltd is a China-based company mainly engaged in drug development business and preclinical research. The Company … WebOct 17, 2024 · BEIJING, October 17, 2024 -- ( BUSINESS WIRE )--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) will present at the upcoming BIO-EUROPE conference in Leipzig,... iron force tank game